Literature DB >> 17657552

Management of chondroblastoma: retrospective review of 28 patients.

Hakan Atalar1, Kerem Basarir, Yusuf Yildiz, Selim Erekul, Yener Saglik.   

Abstract

BACKGROUND: This study retrospectively reviewed 28 patients who presented with chondroblastoma in our hospital during the period March 1986 to February 2006. We investigated factors associated with local recurrence of the tumors after surgery.
METHODS: We recorded the patients' sex and age, the location of the pathology, imaging studies (status of growth plate and activity of lesions), histological findings, and treatment outcomes.
RESULTS: Pain was the presenting symptom in all patients. The tumors were generally located in the epiphyses or apophyses of long bones, especially in the proximal humerus (9 patients), proximal tibia (7 patients), and proximal femur (5 patients). Our preferred treatment method was generally aggressive curettage of the lesion followed by bone grafting. There was local recurrence in six patients. A secondary aneurysmal bone cyst was present in two patients.
CONCLUSION: Aggressive curettage and bone grafting resulted in local control in most patients. Tumor recurrence was not statistically associated with age, sex, growth plate status, tumor location, or tumor activity. The only parameter associated with increased local recurrence was previous surgery for chondroblastoma in the same location.

Entities:  

Mesh:

Year:  2007        PMID: 17657552     DOI: 10.1007/s00776-007-1141-2

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  13 in total

1.  Chondroblastoma in adult age.

Authors:  Andrea Angelini; Mohammad Hassani; Andreas F Mavrogenis; Giulia Trovarelli; Carlo Romagnoli; Antonio Berizzi; Pietro Ruggieri
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-06-20

Review 2.  Metaphyseal and diaphyseal chondroblastomas.

Authors:  Aditya V Maheshwari; James S Jelinek; Albert J Song; Kenneth J Nelson; Mark D Murphey; Robert M Henshaw
Journal:  Skeletal Radiol       Date:  2011-07-20       Impact factor: 2.199

3.  Radiofrequency ablation of chondroblastoma: long-term clinical and imaging outcomes.

Authors:  Cheng Xie; Lee Jeys; Steven L J James
Journal:  Eur Radiol       Date:  2014-11-30       Impact factor: 5.315

Review 4.  Bone and soft tissue ablation.

Authors:  Ryan C B Foster; Joseph M Stavas
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

5.  Image guided radiofrequency thermo-ablation therapy of chondroblastomas: should it replace surgery?

Authors:  Radhesh K Lalam; Gillian L Cribb; Bernard J Tins; Wim P Cool; Jaspreet Singh; Prudencia N M Tyrrell; Victor N Cassar-Pullicino
Journal:  Skeletal Radiol       Date:  2014-01-31       Impact factor: 2.199

Review 6.  Chondroblastoma in the long bone diaphysis: a report of two cases with literature review.

Authors:  Jilong Yang; Wei Tian; Xiongzeng Zhu; Jian Wang
Journal:  Chin J Cancer       Date:  2012-03-27

7.  Subperiostial recurrence of chondroblastoma.

Authors:  Sumanth Reddy; Michael Deavers; Patrick Lin; Tamara Miner Haygood
Journal:  Radiol Case Rep       Date:  2015-11-06

8.  Use of extended curettage with osteotomy and fenestration followed by reconstruction with conservation of muscle insertion in the treatment of Enneking stage II locally aggressive bone tumor of the proximal extremities: resection and treatment of bone tumors.

Authors:  Feiyan Chen; Jun Xia; Siqun Wang; Yibing Wei; Jianguo Wu; Gangyong Huang; Jie Chen; Jingsheng Shi
Journal:  World J Surg Oncol       Date:  2013-03-05       Impact factor: 2.754

9.  Chondroblastoma associated with aneurysmal cyst of the navicular bone: a case report.

Authors:  Zhenhua Fang; Ming Chen
Journal:  World J Surg Oncol       Date:  2013-02-28       Impact factor: 2.754

10.  Chondroblastoma of the Medial Malleolus: A Case Report of A Rare Tumor at an Extremely Uncommon Site.

Authors:  Mukesh Tiwari; Hemant Chaturvedi; Vaibhav Patel; Rajarshi Matti
Journal:  J Orthop Case Rep       Date:  2016 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.